Torren Management’s Upstream Bio Inc UPB Stock Holding History

Torren Management’s Portfolio UPB Stock Details UPB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-162	Closed	-$1.46K	–	984
2026 Q1	$1.46K	Sell	162 -937	-85%	-$16.9K	﹤0.01%	648
2025 Q4	$29.8K	Buy	+1,099	New	+$27.4K	0.02%	475

Other funds holding UPB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

Torren Management's UPB Position: Q2 2026 in Review

Torren Management sold out of Upstream Bio Inc (UPB) in Q2 2026, closing a stake of 162 shares — an estimated $1.46K sold.

Torren Management first reported a position in UPB in Q4 2025 and held it in 2 quarters. The position peaked at $29.8K in Q4 2025. 38 funds tracked by Wall St. Rank hold UPB as of Q2 2026.

Torren Management reported no remaining Upstream Bio Inc position as of Q2 2026 after selling out during the quarter.
Torren Management sold 162 Upstream Bio Inc shares in Q2 2026, an estimated $1.46K.
Torren Management first reported a position in Upstream Bio Inc in Q4 2025 and held it in 2 quarters.
Torren Management's Upstream Bio Inc position peaked at $29.8K in Q4 2025.
38 funds tracked by Wall St. Rank held Upstream Bio Inc as of Q2 2026.

Based on Torren Management's 13F filing for Q2 2026, filed 10 Jul 2026.